APO Research
Talk to an analyst

APO RESEARCH · REPORT

Microneedle Flu Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Microneedle Flu Vaccine Market Outlook and Growth Opportunities 2026

30 December 2025198 pages

Choose your research edition.

Industry ResearchMicroneedle Flu Vaccine Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Microneedle Flu Vaccine Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Microneedle Flu Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Microneedle Flu Vaccine Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Microneedle Flu Vaccine Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Microneedle Flu Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Microneedle Flu Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Microneedle Flu Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Microneedle Flu Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Microneedle Flu Vaccine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Microneedle Flu Vaccine market include Sanofi, NanoPass Technologies, Microdermics and OraSure Technologies, GC Pharma, FluGen, Debiotech, CosMED Pharmaceuticals, Corium International and Becton Dickinson and Company, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Microneedle Flu Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Microneedle Flu Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Microneedle Flu Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Microneedle Flu Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Microneedle Flu Vaccine Segment by Company

Sanofi

NanoPass Technologies

Microdermics and OraSure Technologies

GC Pharma

FluGen

Debiotech

CosMED Pharmaceuticals

Corium International

Becton Dickinson and Company

Microneedle Flu Vaccine Segment by Type

Hollow Microneedle

Coated Microneedle

Solid Microneedle

Dissolving Microneedle

Microneedle Flu Vaccine Segment by Application

Influenza A

Influenza B

Microneedle Flu Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Microneedle Flu Vaccine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Microneedle Flu Vaccine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Microneedle Flu Vaccine significant trends, drivers, influence factors in global and regions.

6. To analyze Microneedle Flu Vaccine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Microneedle Flu Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Microneedle Flu Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Microneedle Flu Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Microneedle Flu Vaccine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Microneedle Flu Vaccine industry.

Chapter 3: Detailed analysis of Microneedle Flu Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Microneedle Flu Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Microneedle Flu Vaccine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Microneedle Flu Vaccine Industry Trends Table 2. Microneedle Flu Vaccine Industry Drivers Table 3. Microneedle Flu Vaccine Industry Opportunities and Challenges Table 4. Microneedle Flu Vaccine Industry Restraints Table 5. Global Microneedle Flu Vaccine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Microneedle Flu Vaccine Revenue Share by Company (2021-2026) Table 7. Global Microneedle Flu Vaccine Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Microneedle Flu Vaccine Sales Volume Share by Company (2021-2026) Table 9. Global Microneedle Flu Vaccine Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Microneedle Flu Vaccine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Microneedle Flu Vaccine Key Company Manufacturing Base & Headquarters Table 12. Global Microneedle Flu Vaccine Company, Product Type & Application Table 13. Global Microneedle Flu Vaccine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Microneedle Flu Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Hollow Microneedle Table 18. Significant Companies of Coated Microneedle Table 19. Significant Companies of Solid Microneedle Table 20. Significant Companies of Dissolving Microneedle Table 21. Global Microneedle Flu Vaccine Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Microneedle Flu Vaccine Sales Volume by Type (2021-2026) & (K Units) Table 23. Global Microneedle Flu Vaccine Sales Volume by Type (2027-2032) & (K Units) Table 24. Global Microneedle Flu Vaccine Sales Volume Share by Type (2021-2026) Table 25. Global Microneedle Flu Vaccine Sales Volume Share by Type (2027-2032) Table 26. Global Microneedle Flu Vaccine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Microneedle Flu Vaccine Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Microneedle Flu Vaccine Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Microneedle Flu Vaccine Sales Value Share by Type (2021-2026) Table 30. Global Microneedle Flu Vaccine Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Influenza A Table 32. Significant Companies of Influenza B Table 33. Global Microneedle Flu Vaccine Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Microneedle Flu Vaccine Sales Volume by Application (2021-2026) & (K Units) Table 35. Global Microneedle Flu Vaccine Sales Volume by Application (2027-2032) & (K Units) Table 36. Global Microneedle Flu Vaccine Sales Volume Share by Application (2021-2026) Table 37. Global Microneedle Flu Vaccine Sales Volume Share by Application (2027-2032) Table 38. Global Microneedle Flu Vaccine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Microneedle Flu Vaccine Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Microneedle Flu Vaccine Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Microneedle Flu Vaccine Sales Value Share by Application (2021-2026) Table 42. Global Microneedle Flu Vaccine Sales Value Share by Application (2027-2032) Table 43. Global Microneedle Flu Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Microneedle Flu Vaccine Sales by Region (2021-2026) & (K Units) Table 45. Global Microneedle Flu Vaccine Sales Market Share by Region (2021-2026) Table 46. Global Microneedle Flu Vaccine Sales by Region (2027-2032) & (K Units) Table 47. Global Microneedle Flu Vaccine Sales Market Share by Region (2027-2032) Table 48. Global Microneedle Flu Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Microneedle Flu Vaccine Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Microneedle Flu Vaccine Sales Value Share by Region (2021-2026) Table 51. Global Microneedle Flu Vaccine Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Microneedle Flu Vaccine Sales Value Share by Region (2027-2032) Table 53. Global Microneedle Flu Vaccine Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Microneedle Flu Vaccine Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Microneedle Flu Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global Microneedle Flu Vaccine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Microneedle Flu Vaccine Sales by Country (2021-2026) & (K Units) Table 58. Global Microneedle Flu Vaccine Sales Market Share by Country (2021-2026) Table 59. Global Microneedle Flu Vaccine Sales by Country (2027-2032) & (K Units) Table 60. Global Microneedle Flu Vaccine Sales Market Share by Country (2027-2032) Table 61. Global Microneedle Flu Vaccine Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Microneedle Flu Vaccine Sales Value Market Share by Country (2021-2026) Table 63. Global Microneedle Flu Vaccine Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Microneedle Flu Vaccine Sales Value Market Share by Country (2027-2032) Table 65. Sanofi Company Information Table 66. Sanofi Business Overview Table 67. Sanofi Microneedle Flu Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Sanofi Microneedle Flu Vaccine Product Portfolio Table 69. Sanofi Recent Development Table 70. NanoPass Technologies Company Information Table 71. NanoPass Technologies Business Overview Table 72. NanoPass Technologies Microneedle Flu Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. NanoPass Technologies Microneedle Flu Vaccine Product Portfolio Table 74. NanoPass Technologies Recent Development Table 75. Microdermics and OraSure Technologies Company Information Table 76. Microdermics and OraSure Technologies Business Overview Table 77. Microdermics and OraSure Technologies Microneedle Flu Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Microdermics and OraSure Technologies Microneedle Flu Vaccine Product Portfolio Table 79. Microdermics and OraSure Technologies Recent Development Table 80. GC Pharma Company Information Table 81. GC Pharma Business Overview Table 82. GC Pharma Microneedle Flu Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. GC Pharma Microneedle Flu Vaccine Product Portfolio Table 84. GC Pharma Recent Development Table 85. FluGen Company Information Table 86. FluGen Business Overview Table 87. FluGen Microneedle Flu Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. FluGen Microneedle Flu Vaccine Product Portfolio Table 89. FluGen Recent Development Table 90. Debiotech Company Information Table 91. Debiotech Business Overview Table 92. Debiotech Microneedle Flu Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Debiotech Microneedle Flu Vaccine Product Portfolio Table 94. Debiotech Recent Development Table 95. CosMED Pharmaceuticals Company Information Table 96. CosMED Pharmaceuticals Business Overview Table 97. CosMED Pharmaceuticals Microneedle Flu Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. CosMED Pharmaceuticals Microneedle Flu Vaccine Product Portfolio Table 99. CosMED Pharmaceuticals Recent Development Table 100. Corium International Company Information Table 101. Corium International Business Overview Table 102. Corium International Microneedle Flu Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Corium International Microneedle Flu Vaccine Product Portfolio Table 104. Corium International Recent Development Table 105. Becton Dickinson and Company Company Information Table 106. Becton Dickinson and Company Business Overview Table 107. Becton Dickinson and Company Microneedle Flu Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Becton Dickinson and Company Microneedle Flu Vaccine Product Portfolio Table 109. Becton Dickinson and Company Recent Development Table 110. Key Raw Materials Table 111. Raw Materials Key Suppliers Table 112. Microneedle Flu Vaccine Distributors List Table 113. Microneedle Flu Vaccine Customers List Table 114. Research Programs/Design for This Report Table 115. Authors List of This Report Table 116. Secondary Sources Table 117. Primary Sources List of Figures Figure 1. Microneedle Flu Vaccine Product Image Figure 2. Global Microneedle Flu Vaccine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Microneedle Flu Vaccine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Microneedle Flu Vaccine Sales (2021-2032) & (K Units) Figure 5. Global Microneedle Flu Vaccine Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Microneedle Flu Vaccine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Hollow Microneedle Image Figure 10. Coated Microneedle Image Figure 11. Solid Microneedle Image Figure 12. Dissolving Microneedle Image Figure 13. Global Microneedle Flu Vaccine Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Microneedle Flu Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Microneedle Flu Vaccine Sales Volume Share by Type (2021-2032) Figure 16. Global Microneedle Flu Vaccine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Microneedle Flu Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Microneedle Flu Vaccine Sales Value Share by Type (2021-2032) Figure 19. Influenza A Image Figure 20. Influenza B Image Figure 21. Global Microneedle Flu Vaccine Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Microneedle Flu Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Microneedle Flu Vaccine Sales Volume Share by Application (2021-2032) Figure 24. Global Microneedle Flu Vaccine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Microneedle Flu Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Microneedle Flu Vaccine Sales Value Share by Application (2021-2032) Figure 27. Global Microneedle Flu Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global Microneedle Flu Vaccine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Microneedle Flu Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Microneedle Flu Vaccine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Microneedle Flu Vaccine Sales Value (2021-2032) & (US$ Million) Figure 32. North America Microneedle Flu Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Microneedle Flu Vaccine Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Microneedle Flu Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Microneedle Flu Vaccine Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Microneedle Flu Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Microneedle Flu Vaccine Sales Value (2021-2032) & (US$ Million) Figure 38. South America Microneedle Flu Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Microneedle Flu Vaccine Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Microneedle Flu Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Microneedle Flu Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Microneedle Flu Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Microneedle Flu Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Microneedle Flu Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Microneedle Flu Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Microneedle Flu Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Microneedle Flu Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Microneedle Flu Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Microneedle Flu Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Microneedle Flu Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Microneedle Flu Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Microneedle Flu Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Microneedle Flu Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Microneedle Flu Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Microneedle Flu Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Microneedle Flu Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Microneedle Flu Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Microneedle Flu Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Microneedle Flu Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Microneedle Flu Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Microneedle Flu Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Microneedle Flu Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Microneedle Flu Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Microneedle Flu Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Microneedle Flu Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Microneedle Flu Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Microneedle Flu Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Microneedle Flu Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Microneedle Flu Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Microneedle Flu Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Microneedle Flu Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Microneedle Flu Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Microneedle Flu Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Microneedle Flu Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Microneedle Flu Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Microneedle Flu Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Microneedle Flu Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Microneedle Flu Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Microneedle Flu Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Microneedle Flu Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Microneedle Flu Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Microneedle Flu Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Microneedle Flu Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Microneedle Flu Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Microneedle Flu Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Microneedle Flu Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Microneedle Flu Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Microneedle Flu Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Microneedle Flu Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Microneedle Flu Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Microneedle Flu Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Microneedle Flu Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Microneedle Flu Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Microneedle Flu Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Microneedle Flu Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Microneedle Flu Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Microneedle Flu Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Microneedle Flu Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Microneedle Flu Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Microneedle Flu Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Microneedle Flu Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Microneedle Flu Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Microneedle Flu Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Microneedle Flu Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Microneedle Flu Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Microneedle Flu Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Microneedle Flu Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Microneedle Flu Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Microneedle Flu Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Microneedle Flu Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Microneedle Flu Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Microneedle Flu Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Microneedle Flu Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Microneedle Flu Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Microneedle Flu Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Microneedle Flu Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Microneedle Flu Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Microneedle Flu Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Microneedle Flu Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Microneedle Flu Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Microneedle Flu Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Microneedle Flu Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Microneedle Flu Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Microneedle Flu Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Microneedle Flu Vaccine Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Microneedle Flu Vaccine Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Hollow Microneedle
  • Coated Microneedle
  • Solid Microneedle
  • Dissolving Microneedle
Applications
  • Influenza A
  • Influenza B
Companies covered
  • Sanofi
  • NanoPass Technologies
  • Microdermics and OraSure Technologies
  • GC Pharma
  • FluGen
  • Debiotech
  • CosMED Pharmaceuticals
  • Corium International
  • Becton Dickinson and Company

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Microneedle Flu Vaccine Sales Value (2021-2032)
  4. 1.2.2 Global Microneedle Flu Vaccine Sales Volume (2021-2032)
  5. 1.2.3 Global Microneedle Flu Vaccine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Microneedle Flu Vaccine Market Dynamics
  1. 2.1 Microneedle Flu Vaccine Industry Trends
  2. 2.2 Microneedle Flu Vaccine Industry Drivers
  3. 2.3 Microneedle Flu Vaccine Industry Opportunities and Challenges
  4. 2.4 Microneedle Flu Vaccine Industry Restraints
3 Microneedle Flu Vaccine Market by Company
  1. 3.1 Global Microneedle Flu Vaccine Company Revenue Ranking in 2025
  2. 3.2 Global Microneedle Flu Vaccine Revenue by Company (2021-2026)
  3. 3.3 Global Microneedle Flu Vaccine Sales Volume by Company (2021-2026)
  4. 3.4 Global Microneedle Flu Vaccine Average Price by Company (2021-2026)
  5. 3.5 Global Microneedle Flu Vaccine Company Ranking (2024-2026)
  6. 3.6 Global Microneedle Flu Vaccine Company Manufacturing Base and Headquarters
  7. 3.7 Global Microneedle Flu Vaccine Company Product Type and Application
  8. 3.8 Global Microneedle Flu Vaccine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Microneedle Flu Vaccine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Microneedle Flu Vaccine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Microneedle Flu Vaccine Market by Type
  1. 4.1 Microneedle Flu Vaccine Type Introduction
  2. 4.1.1 Hollow Microneedle
  3. 4.1.2 Coated Microneedle
  4. 4.1.3 Solid Microneedle
  5. 4.1.4 Dissolving Microneedle
  6. 4.2 Global Microneedle Flu Vaccine Sales Volume by Type
  7. 4.2.1 Global Microneedle Flu Vaccine Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Microneedle Flu Vaccine Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Microneedle Flu Vaccine Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Microneedle Flu Vaccine Sales Value by Type
  11. 4.3.1 Global Microneedle Flu Vaccine Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Microneedle Flu Vaccine Sales Value by Type (2021-2032)
  13. 4.3.3 Global Microneedle Flu Vaccine Sales Value Share by Type (2021-2032)
5 Microneedle Flu Vaccine Market by Application
  1. 5.1 Microneedle Flu Vaccine Application Introduction
  2. 5.1.1 Influenza A
  3. 5.1.2 Influenza B
  4. 5.2 Global Microneedle Flu Vaccine Sales Volume by Application
  5. 5.2.1 Global Microneedle Flu Vaccine Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Microneedle Flu Vaccine Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Microneedle Flu Vaccine Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Microneedle Flu Vaccine Sales Value by Application
  9. 5.3.1 Global Microneedle Flu Vaccine Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Microneedle Flu Vaccine Sales Value by Application (2021-2032)
  11. 5.3.3 Global Microneedle Flu Vaccine Sales Value Share by Application (2021-2032)
6 Microneedle Flu Vaccine Regional Sales and Value Analysis
  1. 6.1 Global Microneedle Flu Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Microneedle Flu Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Microneedle Flu Vaccine Sales by Region: 2021-2026
  4. 6.2.2 Global Microneedle Flu Vaccine Sales by Region (2027-2032)
  5. 6.3 Global Microneedle Flu Vaccine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Microneedle Flu Vaccine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Microneedle Flu Vaccine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Microneedle Flu Vaccine Sales Value by Region (2027-2032)
  9. 6.5 Global Microneedle Flu Vaccine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Microneedle Flu Vaccine Sales Value (2021-2032)
  12. 6.6.2 North America Microneedle Flu Vaccine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Microneedle Flu Vaccine Sales Value (2021-2032)
  15. 6.7.2 Europe Microneedle Flu Vaccine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Microneedle Flu Vaccine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Microneedle Flu Vaccine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Microneedle Flu Vaccine Sales Value (2021-2032)
  21. 6.9.2 South America Microneedle Flu Vaccine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Microneedle Flu Vaccine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Microneedle Flu Vaccine Sales Value Share by Country, 2025 VS 2032
7 Microneedle Flu Vaccine Country-level Sales and Value Analysis
  1. 7.1 Global Microneedle Flu Vaccine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Microneedle Flu Vaccine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Microneedle Flu Vaccine Sales by Country (2021-2032)
  4. 7.3.1 Global Microneedle Flu Vaccine Sales by Country (2021-2026)
  5. 7.3.2 Global Microneedle Flu Vaccine Sales by Country (2027-2032)
  6. 7.4 Global Microneedle Flu Vaccine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Microneedle Flu Vaccine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Microneedle Flu Vaccine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Microneedle Flu Vaccine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Microneedle Flu Vaccine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Microneedle Flu Vaccine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Microneedle Flu Vaccine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Microneedle Flu Vaccine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Microneedle Flu Vaccine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Microneedle Flu Vaccine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Microneedle Flu Vaccine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Microneedle Flu Vaccine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Microneedle Flu Vaccine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Microneedle Flu Vaccine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Microneedle Flu Vaccine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Microneedle Flu Vaccine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Microneedle Flu Vaccine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Microneedle Flu Vaccine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Microneedle Flu Vaccine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Microneedle Flu Vaccine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Microneedle Flu Vaccine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Microneedle Flu Vaccine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Microneedle Flu Vaccine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Microneedle Flu Vaccine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Microneedle Flu Vaccine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Microneedle Flu Vaccine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Microneedle Flu Vaccine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Microneedle Flu Vaccine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Microneedle Flu Vaccine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Microneedle Flu Vaccine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Microneedle Flu Vaccine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Microneedle Flu Vaccine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Microneedle Flu Vaccine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Microneedle Flu Vaccine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Microneedle Flu Vaccine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Microneedle Flu Vaccine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Microneedle Flu Vaccine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Microneedle Flu Vaccine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Microneedle Flu Vaccine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Microneedle Flu Vaccine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Microneedle Flu Vaccine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Microneedle Flu Vaccine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Microneedle Flu Vaccine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Microneedle Flu Vaccine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Microneedle Flu Vaccine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Microneedle Flu Vaccine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Microneedle Flu Vaccine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Microneedle Flu Vaccine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Microneedle Flu Vaccine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Microneedle Flu Vaccine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Microneedle Flu Vaccine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Microneedle Flu Vaccine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Microneedle Flu Vaccine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Microneedle Flu Vaccine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Microneedle Flu Vaccine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Microneedle Flu Vaccine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Microneedle Flu Vaccine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Microneedle Flu Vaccine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Microneedle Flu Vaccine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Microneedle Flu Vaccine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Microneedle Flu Vaccine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Microneedle Flu Vaccine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Microneedle Flu Vaccine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Microneedle Flu Vaccine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Microneedle Flu Vaccine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Microneedle Flu Vaccine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Microneedle Flu Vaccine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Microneedle Flu Vaccine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Microneedle Flu Vaccine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Microneedle Flu Vaccine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Microneedle Flu Vaccine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Microneedle Flu Vaccine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Microneedle Flu Vaccine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Microneedle Flu Vaccine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Microneedle Flu Vaccine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Microneedle Flu Vaccine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Microneedle Flu Vaccine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Microneedle Flu Vaccine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Microneedle Flu Vaccine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Microneedle Flu Vaccine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Microneedle Flu Vaccine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Microneedle Flu Vaccine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Microneedle Flu Vaccine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Microneedle Flu Vaccine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Microneedle Flu Vaccine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Microneedle Flu Vaccine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Microneedle Flu Vaccine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi
  2. 8.1.1 Sanofi Company Information
  3. 8.1.2 Sanofi Business Overview
  4. 8.1.3 Sanofi Microneedle Flu Vaccine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Microneedle Flu Vaccine Product Portfolio
  6. 8.1.5 Sanofi Recent Developments
  7. 8.2 NanoPass Technologies
  8. 8.2.1 NanoPass Technologies Company Information
  9. 8.2.2 NanoPass Technologies Business Overview
  10. 8.2.3 NanoPass Technologies Microneedle Flu Vaccine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 NanoPass Technologies Microneedle Flu Vaccine Product Portfolio
  12. 8.2.5 NanoPass Technologies Recent Developments
  13. 8.3 Microdermics and OraSure Technologies
  14. 8.3.1 Microdermics and OraSure Technologies Company Information
  15. 8.3.2 Microdermics and OraSure Technologies Business Overview
  16. 8.3.3 Microdermics and OraSure Technologies Microneedle Flu Vaccine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Microdermics and OraSure Technologies Microneedle Flu Vaccine Product Portfolio
  18. 8.3.5 Microdermics and OraSure Technologies Recent Developments
  19. 8.4 GC Pharma
  20. 8.4.1 GC Pharma Company Information
  21. 8.4.2 GC Pharma Business Overview
  22. 8.4.3 GC Pharma Microneedle Flu Vaccine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 GC Pharma Microneedle Flu Vaccine Product Portfolio
  24. 8.4.5 GC Pharma Recent Developments
  25. 8.5 FluGen
  26. 8.5.1 FluGen Company Information
  27. 8.5.2 FluGen Business Overview
  28. 8.5.3 FluGen Microneedle Flu Vaccine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 FluGen Microneedle Flu Vaccine Product Portfolio
  30. 8.5.5 FluGen Recent Developments
  31. 8.6 Debiotech
  32. 8.6.1 Debiotech Company Information
  33. 8.6.2 Debiotech Business Overview
  34. 8.6.3 Debiotech Microneedle Flu Vaccine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Debiotech Microneedle Flu Vaccine Product Portfolio
  36. 8.6.5 Debiotech Recent Developments
  37. 8.7 CosMED Pharmaceuticals
  38. 8.7.1 CosMED Pharmaceuticals Company Information
  39. 8.7.2 CosMED Pharmaceuticals Business Overview
  40. 8.7.3 CosMED Pharmaceuticals Microneedle Flu Vaccine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 CosMED Pharmaceuticals Microneedle Flu Vaccine Product Portfolio
  42. 8.7.5 CosMED Pharmaceuticals Recent Developments
  43. 8.8 Corium International
  44. 8.8.1 Corium International Company Information
  45. 8.8.2 Corium International Business Overview
  46. 8.8.3 Corium International Microneedle Flu Vaccine Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Corium International Microneedle Flu Vaccine Product Portfolio
  48. 8.8.5 Corium International Recent Developments
  49. 8.9 Becton Dickinson and Company
  50. 8.9.1 Becton Dickinson and Company Company Information
  51. 8.9.2 Becton Dickinson and Company Business Overview
  52. 8.9.3 Becton Dickinson and Company Microneedle Flu Vaccine Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Becton Dickinson and Company Microneedle Flu Vaccine Product Portfolio
  54. 8.9.5 Becton Dickinson and Company Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Microneedle Flu Vaccine Value Chain Analysis
  2. 9.1.1 Microneedle Flu Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Microneedle Flu Vaccine Sales Mode & Process
  6. 9.2 Microneedle Flu Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Microneedle Flu Vaccine Distributors
  9. 9.2.3 Microneedle Flu Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst